The primary objective is to evaluate longitudinal developmental changes in brain structure in patients aged 6-18 years with SCD. The secondary objective is to analyze the longitudinal relations between biomarkers, demographic characteristics, brain…
ID
Source
Brief title
Condition
- Structural brain disorders
- Vascular haemorrhagic disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
• Total white matter volume increase in children and adolescents with SCD
Secondary outcome
• Neurocognitive functioning (intelligence, specific neurocognitive functions,
network organization)
• Incidence of stroke
• Other forms complications due to SCD
• Amount of hospital admissions, day care admissions (adult care only), crises
at home, contact moments with the sickle cell center, ER visits
• Biomarkers for anemia, hemolysis, inflammation and endothelial activation.
• Behavioral functioning
Background summary
Sickle cell disease (SCD) is a hereditary red blood cell blood disorder with a
prevalence of approximately 2,000 patients in the Netherlands. It is
characterized by chronic hemolytic anemia, recurrent painful vaso-occlusive
ischemic events, a higher risk of overwhelming bacterial infections due to
functional asplenia, and progressive multi-organ damage leading to a lower life
expectancy. A severe complication of SCD, which greatly affects health-related
quality of life, is cognitive decline. Although this may be accompanied by
neurological sequelae identifiable on brain imaging techniques, this may also
occur without imaging abnormalities. Particularly, patients with severe SCD
(HbSS or HbSβº genotype) are at an increased risk for cerebral infarcts, both
of arterial and venous origin, as well as silent infarctions. Advanced
techniques in Magnetic Resonance Imaging (MRI) have recently revealed even
more prevalent volumetric and microstructural white matter abnormalities. In
comparison to non-SCD children, it has been demonstrated that white and grey
matter volume expand significantly slower in SCD. Advanced neuroradiology in
SCD has only been performed in research settings and clinical implications of
these structural brain changes and the association between different
radiographic findings and their chronological sequence in appearance, are yet
to be determined.
Study objective
The primary objective is to evaluate longitudinal developmental changes in
brain structure in patients aged 6-18 years with SCD. The secondary objective
is to analyze the longitudinal relations between biomarkers, demographic
characteristics, brain structure, neurocognitive functioning, behavioral
functioning and developmental changes in brain structure.
Study design
Longitudinal cohort study (BRICK) with a duration of 4 years.
Study burden and risks
By creating an advanced model for structural neurological, neurocognitive
functioning in SCD, we will gain more insight into the pathophysiological
origins and risk factors for SCD-related brain abnormalities. This will support
development of preventive and supportive strategies as well as the initiation
and evaluation of therapeutic interventions. Previous experience with the
performance of brain MRI scans combined with recent research, indicates that
the emotional burden placed on young children when undergoing a brain MR scan,
are proportionate to the emotional burden placed on adults when they undergo a
brain MR-scan. Furthermore, children will be offered the opportunity to become
acquainted with the research procedure by witnessing an MRI scan session prior
before participation.
Wytemaweg 80
Rotterdam 3015 CN
NL
Wytemaweg 80
Rotterdam 3015 CN
NL
Listed location countries
Age
Inclusion criteria
• Patients with sickle cell disease of all genotypes;
Exclusion criteria
• Parents/ guardians (in case of minors) or patients themselves (>16 years)
unable to make an informed decision on participating in this study.
• An abnormal brain MRI prior to initiation of the study due to non-SCD related
causes.
• Contraindications for brain MRI per protocol
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL79987.078.21 |